87 related articles for article (PubMed ID: 24145224)
1. Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study.
Dujic T; Zhou K; Tavendale R; Palmer CN; Pearson ER
Diabetes Care; 2016 Nov; 39(11):1896-1901. PubMed ID: 27493135
[TBL] [Abstract][Full Text] [Related]
2. Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study.
Dujic T; Zhou K; Donnelly LA; Tavendale R; Palmer CN; Pearson ER
Diabetes; 2015 May; 64(5):1786-93. PubMed ID: 25510240
[TBL] [Abstract][Full Text] [Related]
3. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.
Pérez-Gómez N; Fernández-Ortega MD; Elizari-Roncal M; Santos-Mazo E; la Maza-Pereg L; Calvo S; Alcaraz R; Sanz-Solas A; Vinuesa R; Saiz-Rodríguez M
Pharmacogenomics; 2023 Aug; 24(12):651-663. PubMed ID: 37610884
[TBL] [Abstract][Full Text] [Related]
4. Influence of Solute Carrier Family 22 Member 1 (
Pradana AD; Kristin E; Nugrahaningsih DAA; Nugroho AK; Pinzon RT
Curr Diabetes Rev; 2024; 20(4):e070823219470. PubMed ID: 37550919
[TBL] [Abstract][Full Text] [Related]
5. Reductions in glucose among postmenopausal women who use and do not use estrogen therapy.
Kim C; Kong S; Laughlin GA; Golden SH; Mather KJ; Nan B; Randolph JF; Edelstein SL; Labrie F; Buschur E; Barrett-Connor E;
Menopause; 2013 Apr; 20(4):393-400. PubMed ID: 23168523
[TBL] [Abstract][Full Text] [Related]
6. Association between the synonymous variant organic cation transporter 3 (OCT3)-1233G>A and the glycemic response following metformin therapy in patients with type 2 diabetes.
Hosseyni-Talei SR; Mahrooz A; Hashemi-Soteh MB; Ghaffari-Cherati M; Alizadeh A
Iran J Basic Med Sci; 2017 Mar; 20(3):250-255. PubMed ID: 28392895
[TBL] [Abstract][Full Text] [Related]
7. Intronic Variants in OCT1 are Associated with All-Cause and Cardiovascular Mortality in Metformin Users with Type 2 Diabetes.
Schweighofer N; Genser B; Maerz W; Kleber ME; Trummer O; Pieber TR; Obermayer-Pietsch B
Diabetes Metab Syndr Obes; 2020; 13():2069-2080. PubMed ID: 32606866
[TBL] [Abstract][Full Text] [Related]
8. Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients.
Umamaheswaran G; Praveen RG; Damodaran SE; Das AK; Adithan C
Clin Exp Med; 2015 Nov; 15(4):511-7. PubMed ID: 25492374
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic variation and metformin response.
Chen S; Zhou J; Xi M; Jia Y; Wong Y; Zhao J; Ding L; Zhang J; Wen A
Curr Drug Metab; 2013 Dec; 14(10):1070-82. PubMed ID: 24329113
[TBL] [Abstract][Full Text] [Related]
10. Organic cation transporter/solute carrier family 22a is involved in drug transfer into milk in mice.
Ito N; Ito K; Ikebuchi Y; Kito T; Miyata H; Toyoda Y; Takada T; Hisaka A; Honma M; Oka A; Kusuhara H; Suzuki H
J Pharm Sci; 2014 Oct; 103(10):3342-8. PubMed ID: 25175747
[TBL] [Abstract][Full Text] [Related]
11. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
[TBL] [Abstract][Full Text] [Related]
12. The pharmacogenetics of type 2 diabetes: a systematic review.
Maruthur NM; Gribble MO; Bennett WL; Bolen S; Wilson LM; Balakrishnan P; Sahu A; Bass E; Kao WH; Clark JM
Diabetes Care; 2014; 37(3):876-86. PubMed ID: 24558078
[TBL] [Abstract][Full Text] [Related]
13. Metformin and Breast Cancer: Where Are We Now?
Cejuela M; Martin-Castillo B; Menendez JA; Pernas S
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269852
[TBL] [Abstract][Full Text] [Related]
14.
Wu K; Li X; Xu Y; Zhang X; Guan Z; Zhang S; Li Y
Int J Endocrinol; 2020; 2020():2975898. PubMed ID: 32454819
[TBL] [Abstract][Full Text] [Related]
15. Measuring the biological effect of presurgical metformin treatment in endometrial cancer.
Sivalingam VN; Kitson S; McVey R; Roberts C; Pemberton P; Gilmour K; Ali S; Renehan AG; Kitchener HC; Crosbie EJ
Br J Cancer; 2016 Feb; 114(3):281-9. PubMed ID: 26794276
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with Metformin.
Cazzaniga M; Bonanni B
Biomed Res Int; 2015; 2015():972193. PubMed ID: 26605341
[TBL] [Abstract][Full Text] [Related]
17. Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
Sui X; Xu Y; Yang J; Fang Y; Lou H; Han W; Zhang M; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan Q; Pan H; Wang X; He C
PLoS One; 2014; 9(5):e97781. PubMed ID: 24849329
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer.
Berstein LM; Iyevleva AG; Vasilyev D; Poroshina TE; Imyanitov EN
Cell Cycle; 2013 Dec; 12(23):3681-8. PubMed ID: 24145224
[TBL] [Abstract][Full Text] [Related]
19. [Genetic testing of constitutive sensitivity to metformin in cancer patients with and without diabetes].
Bershteĭn LM; Vasil'ev DA; Ievleva AG; Imianitov EN
Vopr Onkol; 2013; 59(6):714-20. PubMed ID: 24624779
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
